Trial intelligence / Profile preview

Fufang Yuxingcao Oral Solution in Pediatric Acute Pharyngitis (Wind-Heat Pattern) – Phase II RCT

CTR20244962Phase 2Active

Sponsor
Conba Pharmaceutical
Start
Mar 2025
Countries
1
01

Overview

A Phase 2 trial of fufang yuxingcao oral solution in acute pharyngitis, sponsored by Conba Pharmaceutical. Started Mar 2025; status: active.

02

Drugs

fufang yuxingcao oral solution
03

Conditions

acute pharyngitis

Beyond the preview

Go deeper on CTR20244962.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20244962.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call